- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00182234
SONICS - Effectiveness of Specialist Oncology Nursing
A Study of the Effectiveness of Specialist Oncology Nursing Case Management in Improving Continuity of Supportive Cancer Care in the Community (SONICS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main Research Question: Does community-based specialist oncology nursing case management improve continuity of cancer care and lead to fewer unmet cancer patient needs?
Why this research is important: This research proposal addresses the issue of gaps in continuity of supportive care for cancer patients during the early phases of the disease trajectory that result in unmet needs and unnecessary morbidity, prior to entry into a formalized cancer care system (e.g., a regional cancer centre or hospital with a cancer treatment program). This initial diagnostic period of cancer is associated with significant stress, anxiety and uncertainty that can impact upon overall quality of life for all types of cancer. These problems are further exacerbated by waiting times of up to 16 weeks between diagnosis and attendance in a formalized cancer treatment system. During this time patients will face a fragmented supportive care service system resulting in a substantial number of patients reporting unmet needs and distress. These care gaps have significant implications considering that 38% of women and 41% of men will develop cancer during their lifetime and that cancer incidence continues to rise with an estimated 139,000 new cases in Canada (over 54,000 of these in Ontario) in 2003. There has been growing interest in nursing models to address these gaps in supportive cancer care but at this time there is not sufficient high quality evidence upon which to base policy decisions to support the widespread introduction of this type of model. The results of this study will be very important for policy development for community cancer care in Ontario and in other provinces in Canada.
What is being studied: We will study the impact of a specialized nursing intervention (Interlink) on patient outcomes early in the disease trajectory. Impact will be assessed directly using validated measures in a randomized controlled trial design. These measures will include: continuity of care, unmet needs, psychological distress, uncertainty in illness, and quality of life.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Histologically confirmed breast or colorectal cancer.
- In the initial stages of surgical consultation within the randomized surgical practices.
- Not had previous or concomitant malignancies (except for: non-melanoma skin cancer, or carcinoma in situ of the cervix).
- Have been informed of cancer diagnosis by the surgical office.
- Reside in the Interlink adult program service area.
- Legally able to provide informed consent (18 years of age or older).
- Able to speak and read English.
- Patients from an intervention designated practice, must agree to referral to Interlink and to receiving an in-home needs assessment.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference in unmet supportive care needs between intervention and control group
Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
|
Difference in continuity of care between intervention and control group
Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
|
Difference in quality of life between intervention and control group
Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference in uncertainty in illness between intervention and control group
Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
|
Difference in use of resources between intervention and control group
Time Frame: 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
2 to 3 weeks after baseline; 8 to 10 weeks after baseline
|
|
Acute stress following surgery
Time Frame: 8 to 10 weeks after baseline
|
8 to 10 weeks after baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jonathan Sussman, MD, CCFP, FRCP (c), MSc, Supportive Cancer Care Research Unit
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 74867
- CIHR - 74867
- MOHLTC - 04171
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.